Previous 10 | Next 10 |
A , AMBA , BECN , CAL , GBDC , HPE , MTSC , NTNX , PANW , PVH , SR For Seeking Alpha's full earnings season calendar, click here . More news on: Agilent Technologies, Inc., Ambarella, Inc., Beacon Roofing Supply, Inc., Earnings news and commentary,
Monitoring dividend increases for stocks on my watch list helps me identify candidates for further analysis. Companies that regularly raise dividends show confidence in the potential growth of future earnings. I look for dividend increase announcements for stocks in the Dividend Champions Li...
Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks, and our single stock focus. If you are interested in listening to Stocks To Watch ...
Introduction The Dividend Champions list is a monthly compilation of companies which have consistently increased their annual dividend payouts, and the latest edition may be found here . However, since this list is only produced once per month, the data in it can quickly get out of date. Fu...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
Agilent Technologies (NYSE: A ) announces that its PD-L1 IHC 22C3 pharmDx assay is now labeled for use in HNSCC in the European Union. More news on: Agilent Technologies, Inc., Healthcare stocks news, Read more ...
PD-L1 IHC 22C3 pharmDx can now be used as an aid in identifying HNSCC patients for treatment with KEYTRUDA ® (pembrolizumab) in Europe Agilent Technologies Inc. (NYSE: A) today announced that its PD-L1 IHC 22C3 pharmDx assay is now labeled for use in HNSCC in the European Union...
I wrote an earnings preview on Agilent ( A ) back in August , and I had a bullish outlook on the company back then. Here is what I stated in my summary paragraph: I think the safest play on Agilent right now is to wait until after the earnings report. I am bullish on the stock, but if the...
Stocks have rallied sharply higher since the early October lows because of perceived progress on China trade talks and dovish Federal Reserve policy. However, that doesn't necessarily mean every stock is worth buying today. A trade deal could still get derailed, and the Fed many not provide fu...
Sponsorship will enable a promising biotech startup to advance scientific discovery Agilent Technologies Inc . (NYSE: A) has announced that the nomination process to submit proposals to receive an Agilent-sponsored LabCentral Golden Ticket is open for interested life sciences and biotec...
News, Short Squeeze, Breakout and More Instantly...
Agilent Technologies Inc. Company Name:
A Stock Symbol:
NYSE Market:
Agilent Technologies Inc. Website:
2024-08-01 15:15:03 ET William Blair analyst issues OUTPERFORM recommendation for A on August 1, 2024 01:31PM ET. The previous analyst recommendation was Outperform. A was trading at $143.26 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
Technology helps high-throughput labs operate more efficiently Agilent Technologies Inc. (NYSE: A) today announced it has acquired Sigsense Technologies , a San Francisco, California-based startup that uses artificial intelligence and power monitoring to help optimize lab operatio...
Expands Agilent’s end-to-end biopharma solutions that accelerate drug discovery, development, and manufacturing Agilent Technologies Inc. (NYSE: A) today announced it has signed a definitive agreement to acquire BIOVECTRA, a leading specialized contract development and manufacturin...